Txoj Kev Siv thiab Txoj Kev: Kev sib koom tes, kev sib haum xeeb thiab yeej-yeej
cov khoom

Cov khoom

Liraglutide CAS: 204656-20-2 Chaw tsim tshuaj paus

Liraglutide, lipopeptide thiab polypeptide, yog ib qho analogue ntawm tib neeg GLP-1 nyob rau hauv uas cov lysine residue ntawm txoj hauj lwm 27 yog hloov los ntawm arginine thiab ib pawg hexadecanoyl txuas rau cov lysine ntxiv ntawm glutamic acid spacer.Nws yog siv nrog kev noj haus thiab kev tawm dag zog los txhim kho glycemic tswj hauv cov neeg laus uas muaj ntshav qab zib hom 2.Liraglutide ua haujlwm raws li glucagon-zoo li peptide-1 receptor agonist thiab ua haujlwm ua tus neeg saib xyuas neuroprotective.


Product Detail

Khoom cim npe

Kev siv thiab cuam tshuam

Liraglutide yog ib hom tshuaj hypoglycemic tshiab uas ua rau AMP-activated protein kinase yog li txhim kho cov tshuaj insulin.Nws tsis tsuas yog muaj cov nyhuv hypoglycemic tseem ceeb, tab sis kuj muaj cov haujlwm ntawm kev poob phaus, txo cov ntshav siab, thiab txhim kho cov ntshav lipid profile.Liraglutide, tib neeg glucagon-zoo li peptide-1 (GLP-1) receptor agonist, slows gastric emptying. , ua rau kom satiety, thiab txo cov neeg mob noj, thaum txo lub hlwb lub siab xav noj thiab cia lub cev kom nce zog siv plays lub luag hauj lwm nyob rau hauv yuag poob;nws tiv thaiv lub siab los ntawm kev tsim cov piam thaj ntau dhau thiab txhawb lub txiav ua kom cov tshuaj insulin ntau dua kom txo cov ntshav qab zib;Tsis tas li ntawd, liraglutide kuj muaj cov txiaj ntsig ntawm lub plawv thiab lub raum tiv thaiv.

Khoom qauv

Phau Ntawv Nkauj 282(1)
260 (1)

Cov khoom ntim:

Phau Ntawv Nkauj 283(1)

Cov ntaub ntawv ntxiv:

Kev sib xyaw C172H265N43O51
Assay 99%
Qhov tshwm sim Dawb hmoov
CAS Nr. 204656-20-2
Ntim 25 KG
Txee lub neej 2 xyoo
Cia Khaws rau hauv qhov chaw txias thiab qhuav
Daim ntawv pov thawj ISO.

  • Yav dhau los:
  • Tom ntej:

  • Sau koj cov lus ntawm no thiab xa tuaj rau peb